359 related articles for article (PubMed ID: 24004972)
21. Optimal b value in diffusion-weighted imaging for differentiation of abdominal lesions.
Koc Z; Erbay G
J Magn Reson Imaging; 2014 Sep; 40(3):559-66. PubMed ID: 24115207
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted MR imaging: role in the differential diagnosis of breast lesions.
Altay C; Balci P; Altay S; Karasu S; Saydam S; Canda T; Dicle O
JBR-BTR; 2014; 97(4):211-6. PubMed ID: 25603628
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
24. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.
Miller FH; Hammond N; Siddiqi AJ; Shroff S; Khatri G; Wang Y; Merrick LB; Nikolaidis P
J Magn Reson Imaging; 2010 Jul; 32(1):138-47. PubMed ID: 20578020
[TBL] [Abstract][Full Text] [Related]
25. Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions: the influence of the choice of b-values.
Peters NH; Vincken KL; van den Bosch MA; Luijten PR; Mali WP; Bartels LW
J Magn Reson Imaging; 2010 May; 31(5):1100-5. PubMed ID: 20432344
[TBL] [Abstract][Full Text] [Related]
26. Value of diffusion weighted imaging in the differential diagnosis of benign and malignant breast lesions at 3.0T MRI.
Jiang XY; Xie QZ; Cao XS; Gao T; Xing CY; Li XL
Genet Mol Res; 2014 Sep; 13(3):7773-9. PubMed ID: 25299091
[TBL] [Abstract][Full Text] [Related]
27. Breast DWI at 3 T: influence of the fat-suppression technique on image quality and diagnostic performance.
Nogueira L; Brandão S; Nunes RG; Ferreira HA; Loureiro J; Ramos I
Clin Radiol; 2015 Mar; 70(3):286-94. PubMed ID: 25555315
[TBL] [Abstract][Full Text] [Related]
28. Diffusion-weighted MR imaging of benign and malignant breast lesions before and after contrast enhancement.
Janka R; Hammon M; Geppert C; Nothhelfer A; Uder M; Wenkel E
Rofo; 2014 Feb; 186(2):130-5. PubMed ID: 23929263
[TBL] [Abstract][Full Text] [Related]
29. Optimization of b value in diffusion-weighted MRI for characterization of benign and malignant gynecological lesions.
Koc Z; Erbay G; Ulusan S; Seydaoglu G; Aka-Bolat F
J Magn Reson Imaging; 2012 Mar; 35(3):650-9. PubMed ID: 22069238
[TBL] [Abstract][Full Text] [Related]
30. Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T.
Bogner W; Pinker-Domenig K; Bickel H; Chmelik M; Weber M; Helbich TH; Trattnig S; Gruber S
Radiology; 2012 Apr; 263(1):64-76. PubMed ID: 22438442
[TBL] [Abstract][Full Text] [Related]
31. Apparent diffusion coefficient in differentiation between malignant and benign breast masses: does size matter?
Wan CW; Lee CY; Lui CY; Fong CY; Lau KC
Clin Radiol; 2016 Feb; 71(2):170-7. PubMed ID: 26688549
[TBL] [Abstract][Full Text] [Related]
32. The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results.
Jin G; An N; Jacobs MA; Li K
Acad Radiol; 2010 Apr; 17(4):456-63. PubMed ID: 20207316
[TBL] [Abstract][Full Text] [Related]
33. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?
Tozaki M; Fukuma E
AJR Am J Roentgenol; 2009 Sep; 193(3):840-9. PubMed ID: 19696300
[TBL] [Abstract][Full Text] [Related]
34. Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy.
Sepahdari AR; Aakalu VK; Setabutr P; Shiehmorteza M; Naheedy JH; Mafee MF
Radiology; 2010 Aug; 256(2):554-64. PubMed ID: 20656840
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted MRI and optimal b-value for characterization of liver lesions.
Kaya B; Koc Z
Acta Radiol; 2014 Jun; 55(5):532-42. PubMed ID: 23982322
[TBL] [Abstract][Full Text] [Related]
36. The role of ADC measurement in differential diagnosis of focal hepatic lesions.
Onur MR; Çiçekçi M; Kayalı A; Poyraz AK; Kocakoç E
Eur J Radiol; 2012 Mar; 81(3):e171-6. PubMed ID: 21353418
[TBL] [Abstract][Full Text] [Related]
37. Diffusion-weighted imaging: Effects of intravascular contrast agents on apparent diffusion coefficient measures of breast malignancies at 3 Tesla.
Nguyen VT; Rahbar H; Olson ML; Liu CL; Lehman CD; Partridge SC
J Magn Reson Imaging; 2015 Sep; 42(3):788-800. PubMed ID: 25611726
[TBL] [Abstract][Full Text] [Related]
38. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
Dong Y; Liu Q
J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of apparent diffusion coefficients to differentiate benign from malignant vertebral bone marrow lesions.
Balliu E; Vilanova JC; Peláez I; Puig J; Remollo S; Barceló C; Barceló J; Pedraza S
Eur J Radiol; 2009 Mar; 69(3):560-6. PubMed ID: 18276098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
